Paeanbio

Pano Therapeautics

This biotechnology company develops small molecule drugs targeting mitochondrial ion channels to treat neurodevelopmental disorders and complex diseases of aging.

IMEL Biotherapeutics

This company develops mitochondrial replacement cell therapies for patients with genetic mitochondrial disorders and age-related diseases.

MitoImmune Therapeutics

This biotechnology firm develops mitochondrial-targeted therapies for patients with inflammatory and rare diseases, including cancer treatment side effects like oral mucositis.

Nanna Therapeutics

The company develops medicines for mitochondrial and age-related diseases for patients with unmet medical needs.

Mighty Therapeutics

This company develops mitochondrial-targeted therapies for patients with rare genetic conditions like Barth syndrome and common age-related diseases.

Stealth Bio

This biotechnology firm develops mitochondrial therapies, including an injectable medicine for patients with the rare genetic condition Barth syndrome.

EsoBiotec

The company develops off-the-shelf in vivo cell therapies to treat cancer and autoimmune diseases for patients and pharmaceutical partners.

Endurance Bio

This biotechnology company develops oral small molecule therapeutics for patients with neurodegenerative and metabolic diseases to restore mitochondrial and lysosomal health.